BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 35858903)

  • 21. Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: results of a multicentre retrospective study.
    Honoré C; Goéré D; Messager M; Souadka A; Dumont F; Piessen G; Elias D; Mariette C;
    Eur J Surg Oncol; 2013 Mar; 39(3):235-41. PubMed ID: 23313257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor.
    Hugen N; Verhoeven RH; Lemmens VE; van Aart CJ; Elferink MA; Radema SA; Nagtegaal ID; de Wilt JH
    Int J Cancer; 2015 Jan; 136(2):333-9. PubMed ID: 24841868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does signet ring cell carcinoma component signify worse outcomes for patients with colorectal cancer?
    Wang L; Hirano Y; Heng G; Ishii T; Kondo H; Hara K; Obara N; Asari M; Kato T; Yamaguchi S
    Asian J Surg; 2021 Jan; 44(1):105-110. PubMed ID: 32295719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy is associated with increased survival from colorectal signet ring cell carcinoma with distant metastasis: A Surveillance, Epidemiology, and End Results database analysis.
    Shi T; Huang M; Han D; Tang X; Chen Y; Li Z; Liu C; Xiang D; Wang T; Chen Y; Wang R; Lei Z; Chu X
    Cancer Med; 2019 Apr; 8(4):1930-1940. PubMed ID: 30864303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant chemotherapy
    Li Y; Ma FH; Xue LY; Tian YT
    World J Gastroenterol; 2020 Feb; 26(8):818-827. PubMed ID: 32148379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in clinicopathological characteristics and computed tomography findings between signet ring cell carcinoma and nonsignet ring cell carcinoma in early and advanced gastric cancer.
    Chen J; Cai R; Ren G; Zhao J; Li H; Guo C; He W; Wu X; Zhang W
    Cancer Med; 2018 Apr; 7(4):1160-1169. PubMed ID: 29533002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological and prognostic features of Borrmann type IV gastric cancer versus other Borrmann types: A unique role of signet ring cell carcinoma.
    Liang C; Liang Y; Ou B; Yuan L; Yuan S
    Saudi J Gastroenterol; 2023; 29(4):240-250. PubMed ID: 37470667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multimodal Therapy Versus Primary Surgery for Gastric and Gastroesophageal Junction Diffuse Type Carcinoma, with a Focus on Signet Ring Cell Carcinoma: A Nationwide Study.
    Gertsen EC; van der Veen A; Brenkman HJF; Brosens LAA; van der Post RS; Verhoeven RHA; Luijten JCHBM; Vissers PAJ; Vegt E; van Hillegersberg R; Siersema PD; Ruurda JP
    Ann Surg Oncol; 2024 Mar; 31(3):1760-1772. PubMed ID: 38127213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma.
    Bu Z; Zheng Z; Li Z; Wu X; Zhang L; Wu A; Zong X; Ji J
    Chin J Cancer Res; 2013 Feb; 25(1):32-8. PubMed ID: 23372339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of serum tumor markers in various pathologic subtypes of gastric cancer.
    Pang C; Ma Y; Shi W; Zi M; Chen J; Liang C; Li X; Liu Z; Du Y
    J Gastrointest Surg; 2024 May; 28(5):694-702. PubMed ID: 38458911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological features and survival outcomes of primary signet ring cell and mucinous adenocarcinoma of colon: retrospective analysis of VACCR database.
    Thota R; Fang X; Subbiah S
    J Gastrointest Oncol; 2014 Feb; 5(1):18-24. PubMed ID: 24490039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.
    Piessen G; Messager M; Leteurtre E; Jean-Pierre T; Mariette C
    Ann Surg; 2009 Dec; 250(6):878-87. PubMed ID: 19855261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signet ring cell cancer of stomach and gastro-esophageal junction: molecular alterations, stage-stratified treatment approaches, and future challenges.
    Kumar NAN; Jose A; Usman N; Rajan K; Munisamy M; Shetty PS; Rao M
    Langenbecks Arch Surg; 2022 Feb; 407(1):87-98. PubMed ID: 34505199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of metastasis between early-onset and late-onset gastric signet ring cell carcinoma.
    Zhou QP; Ge YH; Liu CY
    BMC Gastroenterol; 2020 Nov; 20(1):380. PubMed ID: 33189128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The differences in biological behavior and gene expression characteristics between pure and mixed early gastric signet ring cell carcinomas.
    Wang X; Li X; Yang P; Qin X; Yu J; Cheng Y; Zhang G; Tang L
    Dig Liver Dis; 2023 Jun; 55(6):815-822. PubMed ID: 36529637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(4):613-21. PubMed ID: 23573307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signet ring cell carcinoma of resectable metastatic colorectal cancer has rare surgical value.
    Fu J; Wu L; Jiang M; Tan Y; Li D; Chen F; Jiang T; Du J
    J Surg Oncol; 2016 Dec; 114(8):1004-1008. PubMed ID: 27891617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma.
    Korphaisarn K; Morris V; Davis JS; Overman MJ; Fogelman DR; Kee BK; Dasari A; Raghav KPS; Shureiqi I; Trupti M; Wolff RA; Eng C; Menter DG; Hamilton S; Kopetz S
    Br J Cancer; 2019 Sep; 121(6):505-510. PubMed ID: 31406299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors correlated with peritoneal carcinomatosis and survival in patients with gastric cancer treated at a single institution in Brazil.
    Fanelli MF; Silva MJ; de Paiva TF; Chinen LT; Guimarães AP; Gimenes DL; Pinheiro ED; Rinck JA; Nicolau UR; Sanches SM; Melo CA; Dettino AL; Cruz MR; de Melo LM; Formiga MN; de Lima VC
    Int J Clin Oncol; 2009 Aug; 14(4):326-31. PubMed ID: 19705243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of signet ring cell carcinoma of the stomach.
    Kim JP; Kim SC; Yang HK
    Surg Oncol; 1994 Aug; 3(4):221-7. PubMed ID: 7834113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.